As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money.
So let's look at two noteworthy recent insider buys.
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money.
So let's look at two noteworthy recent insider buys.
On Thursday, Vertex Pharmaceuticals' CEO & President, Reshma Kewalramani, made a $1.96M buy of VRTX, purchasing 10,000 shares at a cost of $195.65 each.
Kewalramani was up about 1.3% on the purchase at the high point of today's trading session, with VRTX trading as high as $198.26 in trading on Monday.
Vertex Pharmaceuticals is trading up about 1.1% on the day Monday.
And at TherapeuticsMD, there was insider buying on Wednesday, by Director Cooper C.
Collins who purchased 1,000,000 shares at a cost of $0.72 each, for a total investment of $725,000.
This purchase marks the first one filed by Collins in the past year.
TherapeuticsMD is trading up about 8.1% on the day Monday.
So far Collins is in the green, up about 13.9% on their purchase based on today's trading high of $0.83.
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider..